Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha Lipoic Acid vs Selenium in Hemodialysis Patients
NCT05266794Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Jan 2019
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of alpha-lipoic acid in end stage renal disease (ESRD) (3 arms), sponsored by Ain Shams University. Primary endpoints: Change in miRNA-126 level at 3 months, Change in ROS level at 3 months and 1 more. Started Jan 2019; status: completed.
02
Drugs
alpha-lipoic acid
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT05266794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05266794.